Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 354,100 shares, a decline of 9.9% from the March 15th total of 393,100 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average trading volume of 113,700 shares, the days-to-cover ratio is currently 3.1 days.
Wall Street Analysts Forecast Growth
ADUS has been the subject of several recent analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. Barclays assumed coverage on shares of Addus HomeCare in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $88.00 target price on the stock. Oppenheimer reissued an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research report on Tuesday, March 26th. William Blair reissued an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Finally, TheStreet raised shares of Addus HomeCare from a “c+” rating to a “b-” rating in a research report on Friday, December 22nd. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $103.83.
Read Our Latest Analysis on ADUS
Institutional Trading of Addus HomeCare
Addus HomeCare Stock Up 0.3 %
ADUS stock opened at $96.99 on Wednesday. The firm’s fifty day simple moving average is $97.24 and its 200-day simple moving average is $91.13. The company has a market capitalization of $1.57 billion, a P/E ratio of 25.26, a price-to-earnings-growth ratio of 1.93 and a beta of 0.95. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. Addus HomeCare has a 12 month low of $77.30 and a 12 month high of $114.97.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, February 26th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.04 by $0.17. The business had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. As a group, equities research analysts forecast that Addus HomeCare will post 4.38 earnings per share for the current year.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
- Five stocks we like better than Addus HomeCare
- What are earnings reports?
- Silicon Motion Proves That AI in Motion Stays in Motion
- What is a buyback in stocks? A comprehensive guide for investors
- Undervalued UnitedHealth Group Won’t Be For Long
- How Investors Can Find the Best Cheap Dividend Stocks
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.